Phase I clinical trial that harnesses CAR-T immunotherapy

City of Hope currently has many clinical trials in progress, a number of which address malignant brain tumors. Our brain tumor team is currently enrolling patients with recurrent brain tumors for a new Phase I clinical trial that harnesses CAR-T immunotherapy to fight advanced brain cancers. This trial uses a patient’s own modified T cells to fight their tumors and is designed to target the tumor head-on by delivering the treatment directly into the brain. 
 
Patients:
If you are a patient interested in learning more about our clinical trials, please email [email protected] or call 626-471-9393.
 
Physicians:
If you are a physician and wish to refer a patient for enrollment, please email us at [email protected] or call 626-471-9393.
 
News media:
Contact us by email at [email protected] or call 626-218-8803.
 
You can learn more about this clinical trial online at ClinicalTrials.gov.